JACKSONVILLE, Fla., March 19 Phlo Corporation(Pink Sheets: PHLC) (the "Company") announced today the completion of its100-for-1 reverse stock split process. According to Nasdaq, the reverse splitwill be reflected in the quotation of the price of the Company's common stockin the public market beginning today.
Shareholders will receive instructions shortly for surrendering theircertificates to the transfer agent in exchange for new certificates reflectingthe reverse split.
Additionally, as of today, the trading symbol for Phlo's common stock is"PHCP.PK".
Phlo is a biotechnology company and a manufacturer and marketer ofproducts (primarily liquids) containing patented and patent-pendingbiotechnologies. Phlo is focusing its technology generation and acquisitionefforts on those technologies related to enhancing cognition and personalperformance, reducing the effects of aging, and preventing or amelioratingcancer.
Certain statements made herein that are not historical constitute"forward-looking" statements within the meaning of the Private LitigationReform Act of 1995 and may contain words such as "anticipate," "believe,""expect," "future," "may," "will," "should," "plan," "projected," "intend,"and similar expressions to identify such forward-looking statements. Suchstatements are based on a number of assumptions and on information andestimates supplied to Phlo Corporation by sources currently available to it.Such assumptions and estimates are subject to uncertainties, contingencies,and other factors, many of which are beyond Phlo Corporation's control.Actual results may differ materially from the statements set forth above.
SOURCE Phlo Corporation